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Introduction
The QT interval duration on an ECG represents the duration of ventricular depolarization and repolarization (1, 2) . It has been suggested that disturbance of cardiac ion channels (1, 2) , decreased autonomic tone (3), and myocardial ischemia/ infarction (4) extend the QT interval duration, but the etiology of the acquired form of QT interval prolongation has not been clearly defined. Recently, several epidemiological studies have shown that QT interval prolongation predicts the risks of clinical arterial disease (5-9) as well as sudden cardiac death (5) . Likewise, a few cross-sectional studies have suggested a positive association between QT interval prolongation and subclinical arterial disease, such as carotid intima media thickness (10) (11) (12) . However, there is significant uncertainty about the association between QT interval prolongation and other forms of subclinical arterial disease.
Aortic pulse wave velocity (PWV) is an established marker for subclinical arterial disease (13, 14) as well as for arterial stiffness (15) . Brachial-ankle PWV (baPWV) has also been shown to be closely associated with aortic PWV and to be an excellent functional marker for subclinical arterial disease (16) .
The present cross-sectional study evaluates the association of baPWV with heart rate-corrected QT interval duration (QTc) in a general population of Japanese.
Methods

Study Population
The Hisayama Study is an ongoing population-based epidemiological study designed to investigate the morbidity and mortality of cardiovascular disease and its risk factors in the town of Hisayama, Japan. The design of the Hisayama Study has been described in detail elsewhere (17) . The present cross-sectional study was based on a screening survey conducted in 2002 and 2003. A total of 3,328 residents aged 40 years or over (77.6 % of the total population of this age group) participated in the examination and underwent a comprehensive assessment including baPWV and ECG. Of these, 242 subjects for whom there was no information on baPWV or ECG, 54 subjects who were likely to have peripheral arterial disease (ankle-brachial index < 0.9), 189 subjects with atrial fibrillation or intraventricular conduction disturbance (QRS interval > 120 ms), 30 subjects with elevated heart rate (> 100 beats/min), 22 subjects who did not take a fasting blood test, 16 subjects taking medication affecting the QT interval duration (i.e., antiarrhythmic drugs, antibiotics, antipsychotic agents or antihistamines) (2), 111 subjects with a history of cardiovascular disease (myocardial infarction, coronary revascularization or stroke), and 30 subjects who refused to participate in the present study were excluded from the analyses. The final study group comprised 2,666 subjects (1,089 men and 1,577 women). 
Measurements of QTc and baPWV
Standard, resting 12-lead ECG was performed using an ECG device (FCP-4266; Fukuda Denshi, Tokyo, Japan) in the supine position in the morning. Heart rate (bpm) and QT interval duration (ms) were determined automatically using the PI-10 ECG Analysis Program (Fukuda Denshi). The program calculated the QT interval duration from the beginning of QRS to the end of the T wave. The QT interval duration was corrected for heart rate by calculating QTc according to Bazett's equation (18) .
The baPWV was measured in the supine position after at least 5 min of rest using a volume-plethysmographic apparatus (Form PWV/ABI; Colin, Komaki, Japan), as described previously (19) . Briefly, cuffs to measure baPWV were wrapped on both brachia and ankles. PWV at the brachia and ankles were recorded using a semiconductor pressure sensor. Volume waveforms were stored with automatic gain analysis and quality adjustment. BaPWV was automatically calculated according to the following equation: baPWV = (La − Lb)/T, with La being the distance from the heart to each ankle, Lb the distance from the heart to the right upper arm, and T the time delay from the right brachial waveform to each ankle waveform.
All clinical examinations including 12-lead ECG, measurement of baPWV and blood test were conducted on the same day.
Relevant Factors
At baseline examination, a self-administrated questionnaire concerning current drug use including antihypertensive agents (e.g., β-blocker, calcium channel blocker, angiotensin converting enzyme inhibitor or angiotensin receptor blocker), smoking, and alcohol intake was completed in advance by each participant and was checked by trained interviewers at the screening. These variables were classified as being either habitual or not. Blood pressure was measured three times 
Statistical Analysis
The age-adjusted frequencies of relevant factors in quartile groups defined by baPWV were calculated by means of the direct method using the total study population as a standard and were compared using age-adjusted logistic regression models. The age-adjusted mean values of QTc and relevant factors in quartile groups defined by baPWV were calculated using covariance analysis and compared using multiple regression models. Multivariate-adjusted mean values of QTc in the four baPWV groups were estimated using multiple regression models including age, gender, hypertension, ECG abnormalities, dyslipidemia, diabetes, obesity, serum calcium and potassium levels, alcohol intake, and habitual smoking.
Comparisons of the relationships of baPWV with QTc among subgroups were carried out by adding an interaction term to the statistical models. p values less than 0.05 were considered statistically significant. Statistical analyses were performed using the SAS program package (SAS Institute, Cary, USA).
Ethical Considerations
The ethics committee of Kyushu University approved this study, all participants provided written informed consent, and the procedures followed were in accordance with national guidelines.
Results
The mean value of QTc was 401.7 ms (SD, 21.5; range, 328.0-494.0) for men and 411.7 ms for women (SD, 23.3; range, 295.0-554.0). Baseline characteristics of male and female participants according to quartile groups defined by baPWV are shown in Tables 1 and 2 , respectively. For men, the quartile groups were defined by baPWV values of less than 1,369, 1,370 to 1,560, 1,561 to 1,840, and 1,841 or greater cm/s; and for women, by baPWV of less than 1,269, 1,270 to 1,493, 1,494 to 1,821, and 1,822 or greater cm/s. The subjects with higher baPWV levels were significantly older. The frequencies of hypertension, dyslipidemia, diabetes, obesity, and alcohol intake increased with rising baPWV levels, while an inverse association was observed for the frequency of habitual smoking. Figure 1 shows the age-adjusted mean values of QTc according to quartiles of the baPWV levels by sex. The ageadjusted mean values of QTc linearly increased with rising baPWV levels for men and women: for men, 396.7, 401.4, 403.2, and 405.6 ms for the 1st to 4th quartile groups, respectively (p< 0.0001 for trend); for women, 405.7, 409.9, 413.8, and 417.4 ms for the 1st to 4th quartile groups, respectively (p< 0.0001 for trend). When the Friedrich formula was used for estimation of QTc, similar associations were observed between baPWV and QTc in both men and women (p< 0.0001 for trend in both sexes). In the following analyses, male and female subjects were combined because the relationships of baPWV to QTc were comparable between men and women. Table 3 shows the age-and sex-adjusted mean values of QTc according to quartiles of the baPWV levels for subgroups of participants defined on the basis of the presence or absence of hypertension, dyslipidemia, diabetes, obesity, ECG abnormalities, alcohol intake, or smoking habits. There were comparable relationships between baPWV and QTc for participants who were and were not hypertensive. Likewise, there were no interactions in the relationships of baPWV with QTc between subgroups defined by every other relevant factor (all p values for interaction > 0.05). There were also comparable relationships of baPWV with QTc between participants who were and were not taking antihypertensive agents or lipid-lowering agents (p for interaction > 0.5). We also estimated the age-and sex-adjusted mean values of QTc according to quartiles of the baPWV levels by the number of relevant factors (Table 4 ). There was a significantly positive relationship between baPWV and QTc in each of the groups defined by a number of cardiovascular risk factors of 0-1, 2-3, and 4-7. Figure 2 shows the multivariate-adjusted mean values of QTc according to quartiles of the baPWV levels. The multivariate-adjusted mean values of QTc significantly increased with rising baPWV levels, even after controlling for age, sex, hypertension, ECG abnormalities, dyslipidemia, diabetes, 
Fig. 1. Age-adjusted mean values of heart rate-corrected QT interval duration according to quartiles of brachial-ankle pulse wave velocity levels for men (solid circles) and women (solid boxes
Discussion
To our knowledge, this is the first study to address the associations between baPWV and QTc in a general population without preexisting cardiovascular disease. In the present analysis, the mean values of QTc increased with rising baPWV levels for both men and women. These associations remained strong and continuous, even after controlling for traditional cardiovascular risk factors, suggesting an independent relationship between subclinical arterial disease (atherosclerosis) and QT interval prolongation.
In the present study, there were strong and continuous relationships between QTc and baPWV, which has been shown to be a functional marker for subclinical atherosclerotic disease in central and peripheral arteries (16, 21) . Ours is the largest study to have investigated the association between subclinical arterial disease and QT interval prolongation, but there have been a few other cross-sectional studies addressing this question using other structural markers of subclinical arterial disease (10) (11) (12) . The Insulin Resistance Atherosclerosis Study (IRAS) investigated the association between carotid intima media thickness and QTc in 912 nondiabetic subjects without coronary artery disease and found a close association between carotid atherosclerosis and QT interval prolongation (10) . The Salzburg Atherosclerosis Prevention Program in Subjects at High Individual Risk also showed a positive correlation between carotid intima media thickness and QT interval duration in 1,199 clinically healthy subjects (11) . These observational data support our hypothesis that subclinical arterial disease is associated with QT interval prolongation.
It is well known that the QT interval is affected by heart rate (18, 22) . In order to control for the confounding effects of heart rate, we used QTc, which was estimated by Bazett's formula, and found significant associations between baPWV and QTc. When the Friedrich formula was used for estimation of QTc instead of Bazett's formula, similar associations were observed. We also investigated the association between baPWV and crude QT interval duration and found significantly positive relationships even after adjustment for heart rate, ECG abnormalities, and other cardiovascular risk factors (data not shown). These results suggest that baPWV is significantly associated with QT interval duration and this association is independent of the effects of heart rate.
The mechanism underlying the association between subclinical arterial disease and the acquired form of QT interval prolongation has not been clearly defined. Subclinical arterial disease and subsequent arterial stiffness may increase ventricular load and, as a consequence, may promote myocardial and electrophysiological remodeling, resulting in QT interval prolongation (23, 24) . Another possible mechanism is that microvascular atherosclerosis in the coronary artery, which is strongly related to systemic arterial disease, may lead to subendocardial ischemia and thus extend QT interval duration (25) .
One limitation of our study is that we have no information on subjects with congenital long QT syndrome. However, the prevalence of the congenital long QT syndrome has been reported to be less than 0.1% (26) . Furthermore, in our subjects the relationship between baPWV and QTc was strong and continuous, even after excluding participants with QT intervals of 440 ms or more (p< 0.0001 for trend). Thus, the influence of congenital long QT syndrome would seem to have been negligible. Another limitation is that information on repeated measurements of baPWV and QTc is limited. This fact made it difficult for us to conduct longitudinal analysis.
In conclusion, we found close associations between baPWV and QTc for men and women without histories of cardiovascular disease. These associations were independent of hypertension, ECG abnormalities, dyslipidemia, diabetes, obesity, alcohol intake, and smoking habits. Thus, subclinical arterial disease appears to contribute to the pathogenesis of QT interval prolongation. Future longitudinal studies are necessary to clarify the causal relationship between subclinical arterial disease and QT interval prolongation. 
